• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18320
Device Problem Material Twisted/Bent (2981)
Patient Problems Hyperglycemia (1905); Irritation (1941)
Event Date 11/24/2020
Event Type  malfunction  
Manufacturer Narrative
The device has not been returned/received to date.If the device is received, a supplemental report will be submitted with the investigation results.We are unable to confirm the bent cannula or to determine if it could have contributed to the reported hyperglycemia.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including confirming the blue soft cannula is inspected for any damage.
 
Event Description
It was reported that the patient's blood glucose levels reached near 500 mg/dl while wearing the pod between 4 and 24 hours.When removed from the infusion site (leg), the pod's cannula was found kinked/bent.As treatment for hyperglycemia, insulin was delivered and a water was consumed.
 
Manufacturer Narrative
The received device had the cannula assembly deployed.The exposed portion of the soft cannula was found bent/kinked, although it cannot be determined when or how this damage occurred.Fluid was able to flow through the fluid path with no signs of struggle.Blood was observed on the adhesive pad, however, no evidence was found that would result in bleeding or skin irritation to occur at the infusion site; a root cause could not be determined.No leaks were found during testing, and no other defects or deficiencies were found that would result in a failure of the device to deliver insulin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD DASH INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
MDR Report Key10960270
MDR Text Key219978495
Report Number3004464228-2020-18982
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385082000020
UDI-Public(01)20385082000020(11)190321(17)210430(10)PD1C10301951
Combination Product (y/n)N
PMA/PMN Number
K192659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 11/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/30/2021
Device Model Number18320
Device Catalogue NumberBLE-I1-529
Device Lot NumberPD1C10301951
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/14/2021
Date Manufacturer Received02/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age37 YR
-
-